Radioiodine is an effective treatment for hyperthyroidism and thyroid cancer. Little is known about patients’ experiences of radioiodine, yet negative beliefs about other novel treatments can influence adherence to precautionary behaviors and side effect experience post treatment. The current study aims to examine the impact of patients’ beliefs about their thyroid condition, radioiodine, and their body on precautionary post-radioiodine behaviors and side effects.
Methods:
This prospective cohort study enrolled adults receiving a first outpatient dose of radioiodine to treat thyroid cancer or hyperthyroidism. Participants completed questionnaires assessing beliefs and understanding of radioiodine pre-treatment at the end of the initial post-dose restriction period and 4 weeks after receiving radioiodine. We also assessed adherence to precautionary post-treatment behaviors and reported side effects.
Results:
Sixty-six patients enrolled in the study, 63 completed the pre-radioiodine and initial post-dose assessments, and 60 completed all three. Overall, participants poorly recalled clinician-imposed post-treatment precautions, but often engaged in additional self-imposed precautions. On average, participants reported 4–5 radioiodine side effects. Participants’ beliefs about radioiodine, their thyroid condition, and their body predicted adoption of additional precautions and side effect attribution (P < 0.05 for each).
Conclusions:
Patients receiving radioiodine have poor recall and may under-adhere to required postdose precautions while adopting unnecessary self-imposed precautions. Patients with maladaptive beliefs before treatment appear to find radioiodine more burdensome and intrusive during the first 4 weeks after treatment.
SissonJC, FreitasJ, McDougallIR, et al.; The American Thyroid Association Taskforce on Radioiodine Safety. Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I: Practice recommendations of the American Thyroid Association. Thyroid, 2011; 21(4):335–346; doi: 10.1089/thy.2010.0403
4.
GrigsbyPW, SiegelBA, BakerS, et al.Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma. JAMA, 2000; 283(17):2272–2274; doi: 10.1001/jama.283.17.2272
5.
BarringtonSF, O’DohertyMJ, KettleAG, et al.Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism. Eur J Nucl Med, 1999; 26(7):686–692; doi: 10.1007/s002590050438
6.
MonsieursM, ThierensH, DierckxRA, et al.Real-life radiation burden to relatives of patients treated with iodine-131: A study in eight centres in Flanders (Belgium). Eur J Nucl Med, 1998; 25(10):1368–1376; doi: 10.1007/s002590050310
7.
GabrielS, Farman-AraB, BourrellyM, et al.Radiation doses to cohabitants of patients undergoing radioiodine ablation for thyroid cancer: Poor compliance with radiation protection guidelines but low radiation exposure. Nucl Med Commun, 2011; 32(9):829–833; doi: 10.1097/MNM.0b013e328347f1c2
8.
KeynesS, LastoriaDA, KellettC, et al.The Hawthorne effect on wearable technology: A systematic review. Br J Surg, 2025; 112(Supplement 6); doi: 10.1093/bjs/znaf042.070
QiaoT, GaoD, TongJ, et al.Anxiety and depression status prior to radioactive iodine therapy among differentiated thyroid cancer patients during the COVID–19 pandemic. Support Care Cancer, 2022; 30(12):10169–10177; doi: 10.1007/s00520-022-07422-7
von MüllerF, HappelC, ReinhardtJ, et al.Evaluation of fear of radiation and isolation before and after radioiodine therapy. Thyroid, 2014; 24(7):1151–1155; doi: 10.1089/thy.2013.0461
13.
FreudenbergLS, MüllerSP, BockischA. Subjective perceptions of patients undergoing radioiodine therapy: Why should we know about them? Eur J Nucl Med Mol Imaging, 2009; 36(11):1743–1744; doi: 10.1007/s00259-009-1188-8
14.
HorneR, CooperV, WilemanV, et al.Supporting adherence to medicines for long-term conditions: A perceptions and practicalities approach based on an extended common-sense model. Eur Psychol, 2019; 24(1):82–96; doi: 10.1027/1016-9040/a000353
15.
OliveiraJ, SousaH, BártoloA, et al.Illness perception and treatment adherence in haemodialysis: A systematic review. Psychol Health Med, 2023; 28(7):1641–1655; doi: 10.1080/13548506.2022.2099559
16.
CrumAJ, HeathcoteLC, MorrisonZ, et al.Changing mindsets about side effects of the COVID-19 vaccination: A randomized controlled trial. Ann Behav Med, 2023; 57(11):901–909; doi: 10.1093/abm/kaad020
17.
BroadbentE, EllisCJ, ThomasJ, et al.Further development of an illness perception intervention for myocardial infarction patients: A randomized controlled trial. J Psychosom Res, 2009; 67(1):17–23; doi: 10.1016/j.jpsychores.2008.12.001
18.
HorneR, ChapmanSCE, ParhamR, et al.Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the necessity-concerns framework. PLoS One, 2013; 8(12):e80633; doi: 10.1371/journal.pone.0080633
19.
BroadbentE, WilkesC, KoschwanezH, et al.A systematic review and meta-analysis of the Brief Illness Perception Questionnaire. Psychol Health, 2015; 30(11):1361–1385; doi: 10.1080/08870446.2015.1070851
20.
NestoriucY, OravEJ, LiangMH, et al.Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care Res., 2010; 62(6):791–799; doi: 10.1002/acr.20160
21.
SawkaAM, StrausS, RodinG, et al.Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial. Cancer, 2015; 121(20):3717–3726; doi: 10.1002/cncr.29548
22.
WallnerLP, Reyes-GastelumD, HamiltonAS, et al.Patient-perceived lack of choice in receipt of radioactive iodine for treatment of differentiated thyroid cancer. J Clin Oncol, 2019; 37(24):2152–2161; doi: 10.1200/jco.18.02228
23.
LeeKJ, ChangSO, JungKY. Experiences with a low-iodine diet: A qualitative study of patients with thyroid cancer receiving radioactive iodine therapy. Eur J Oncol Nurs, 2016; 23:43–50; doi: 10.1016/j.ejon.2016.02.011
ZionSR. From Cancer to COVID-19: The Self-Fulfilling Effects of Illness Mindsets on Physical, Social, and Emotional Functioning (Publication No. 29003843) [Doctoral Dissertation, Stanford University]. ProQuest Dissertations & Theses Global; 2021.
27.
MacKrillK, WebsterR, RubinGJ, et al.When symptoms become side effects: Development of the side effect attribution scale (SEAS). J Psychosom Res, 2021; 141:110340; doi: 10.1016/j.jpsychores.2020.110340
ChongYY, ChienWT, ChengHY, et al.The role of illness perceptions, coping, and self-efficacy on adherence to precautionary measures for COVID-19. Int J Environ Res Public Health, 2020; 17(18):6540; doi: 10.3390/ijerph17186540
30.
AujlaN, WalkerM, SpriggN, et al.Can illness beliefs, from the common-sense model, prospectively predict adherence to self-management behaviours? A systematic review and meta-analysis. Psychol Health, 2016; 31(8):931–958; doi: 10.1080/08870446.2016.1153640
31.
AbubakariA, CousinsR, ThomasC, et al.Sociodemographic and clinical predictors of self-management among people with poorly controlled type 1 and type 2 diabetes: The role of illness perceptions and self-efficacy. J Diabetes Res, 2016; 2016(1):6708164; doi: 10.1155/2016/6708164
32.
JonesCJ, SmithHE, LlewellynCD. A systematic review of the effectiveness of interventions using the Common Sense Self-Regulatory Model to improve adherence behaviours. J Health Psychol, 2016; 21(11):2709–2724; doi: 10.1177/1359105315583372
33.
ShamsuddinS, MaziahS, AhmadN, et al.The role of illness perception in the physical activity domain of health-promoting lifestyle among patients with non-communicable diseases: A systematic review. PLoS One, 2024; 19(11):e0311427; doi: 10.1371/journal.pone.0311427
34.
BoswellMA, EvansKM, GhandwaniD, et al.A randomized clinical trial testing digital mindset intervention for knee osteoarthritis pain and activity improvement. NPJ Digit Med, 2024; 7(1):285; doi: 10.1038/s41746-024-01281-8
35.
ChangchienT-C, YenY-C, LuY-C. Mental health and quality of life of patients with differentiated thyroid cancer pre and post radioactive iodine treatment: A prospective study. J Clin Med, 2024; 13(18):5472; doi: 10.3390/jcm13185472
36.
ZdanowskaJ, StangierskiA, SowinskiJ, et al.Subclinical hyperthyroid patients’ knowledge about radioiodine therapy: The key role of medical information. Neuro Endocrinol Lett, 2010; 31(6):775–781.
37.
NguyenMH, SmetsEMA, BolN, et al.Fear and forget: How anxiety impacts information recall in newly diagnosed cancer patients visiting a fast-track clinic. Acta Oncol, 2019; 58(2):182–188; doi: 10.1080/0284186X.2018.1512156
38.
MoranTP. Anxiety and working memory capacity: A meta-analysis and narrative review. Psychol Bull, 2016; 142(8):831–864; doi: 10.1037/bul0000051
39.
BonnemaSJ, HegedüsL. Radioiodine therapy in benign thyroid diseases: Effects, side effects, and factors affecting therapeutic outcome. Endocr Rev, 2012; 33(6):920–980; doi: 10.1210/er.2012-1030
40.
KitaT, YokoyamaK, HiguchiT, et al.Multifactorial analysis on the short-term side effects occurring within 96 hour after radioiodine-131 therapy for differentiated thyroid carcinoma. Ann Nucl Med, 2004; 18(4):345–349; doi: 10.1007/BF02984474
41.
CollocaL. The nocebo effect. Annu Rev Pharmacol Toxicol, 2024; 64:171–190; doi: 10.1146/annurev-pharmtox-022723-112425
42.
PetrieKJ, RiefW. Psychobiological mechanisms of placebo and nocebo effects: Pathways to improve treatments and reduce side effects. Annu Rev Psychol, 2019; 70:599–625; doi: 10.1146/annurev-psych-010418-102907
43.
YielderR, LeibowitzK, CrumAJ, et al.Changing mindsets about methotrexate in the rheumatology clinic to reduce side effects and improve adherence: A randomized controlled trial. Ann Behav Med, 2025; 59(1):kaae089; doi: 10.1093/abm/kaae089
44.
NestoriucY, von BlanckenburgP, SchurichtF, et al.Is it best to expect the worst? Influence of patients’ side-effect expectations on endocrine treatment outcome in a 2-year prospective clinical cohort study. Ann Oncol, 2016; 27(10):1909–1915; doi: 10.1093/annonc/mdw266
45.
StammM. Waves and radiation: Television sets and the fear of biological harm in the cold war. Hist J Film Radio TV, 2025; 45(3):535–555; doi: 10.1080/01439685.2025.2482293
46.
HoggJ. ‘The family that feared tomorrow’: British nuclear culture and individual experience in the late 1950s. Br J Hist Sci, 2012; 45(4):535–549; doi: 10.1017/S0007087412001045
47.
KoernerCL. Media, fear, and nuclear energy: A case study. Soc Sci J, 2014; 51(2):240–249; doi: 10.1016/j.soscij.2013.07.011
48.
Drottz-SjobergBM, PerssonL. Public reaction to radiation: Fear, anxiety, or phobia? Health Phys, 1993; 64(3):223–231; doi: 10.1097/00004032-199303000-00001
49.
FaasseK, PetrieKJ. The nocebo effect: Patient expectations and medication side effects. Postgrad Med J, 2013; 89(1055):540–546; doi: 10.1136/postgradmedj-2012-131730
50.
CollocaL, BarskyAJ. Placebo and nocebo effects. N Engl J Med, 2020; 382(6):554–561; doi: 10.1056/NEJMra1907805
51.
CarrAL, JenkinsAM, JonklaasJ, et al.Patient and provider perspectives of a web-based intervention to support symptom management after radioactive iodine treatment for differentiated thyroid cancer: Qualitative study. JMIR Form Res, 2025; 9:e60588; doi: 10.2196/60588
52.
LiuT, ZhangW, XiaoS, et al.Mindfulness-based stress reduction in patients with differentiated thyroid cancer receiving radioactive iodine therapy: A randomized controlled trial. Cancer Manag Res, 2019; 11:467–474; doi: 10.2147/CMAR.S183299
53.
LiuY-B, ZuoL-J, LiuY-C, et al.Effect of psychological intervention on differentiated thyroid cancer patients in the treatment with radioactive iodine. Patient Prefer Adherence, 2023; 17:731–738; doi: 10.2147/PPA.S400832
54.
HoweLC, LeibowitzKA, PerryMA, et al.Changing patient mindsets about non–life-threatening symptoms during oral immunotherapy: A randomized clinical trial. J Allergy Clin Immunol Pract, 2019; 7(5):1550–1559; doi: 10.1016/j.jaip.2019.01.022
55.
PetrieKJ, WeinmanJ. Patients’ perceptions of their illness: The dynamo of volition in health care. Curr Dir Psychol Sci, 2012; 21(1):60–65; doi: 10.1177/0963721411429456
56.
ZionSR, SchapiraL, BerekJS, et al.Changing cancer mindsets: A randomized controlled feasibility and efficacy trial. Psychooncology, 2023; 32(9):1433–1442; doi: 10.1002/pon.6194
57.
WuH-X, ZhongH, XuY-D, et al.Psychological and behavioral intervention improves the quality of life and mental health of patients suffering from differentiated thyroid cancer treated with postoperative radioactive iodine-131. Neuropsychiatr Dis Treat, 2016; 12:1055–1060; doi: 10.2147/NDT.S105460
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
